Company Badge
USPTO Data Jan 1 1976 - Oct 27 2026
4 Patents
#423 in Seattle, WA
#1,465 in Washington
#60,704 in US
Illumigen Biosciences, Inc.
Forward Citations = 18
10 inventors:
Seattle, WA, United States of America
Illumigen Biosciences, Inc.
Calculating rank
% Expired Patents = 100.0
EPO Patents = 1
Forward Citations = 18
Loading Chart...
Loading Chart...
10 inventors (with patents filed for the assignee):
Charles Lee Magness (3 out of 15 patents)
Dake Sun (2 out of 2 patents)
Shawn P Iadonato (1 out of 29 patents)
4. Christina A Scherer (1 out of 12 patents)
5. Gary Rosenberg (1 out of 5 patents)
6. Mark Branum (1 out of 5 patents)
7. Maralee McVean (1 out of 7 patents)
8. Roger Bumgarner (1 out of 1 patent)
9. Mariya Smit (1 out of 1 patent)
10. Michael G Katze (1 out of 15 patents)
11. Michael Katze (0 patent)
12. Mariya Smit (0 patent)
4 patents:
Company Overview
Illumigen Biosciences, Inc. is a biotechnology company focused on developing innovative therapies for cancer and other diseases. Our cutting-edge research and development platform, combined with a team of experienced scientists and industry experts, enables us to bring novel treatments to market quickly and efficiently.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Illumigen Biosciences, Inc.. Retrieved from https://idiyas.com/company/illumigen-biosciences
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]